2023
DOI: 10.3390/ijms24065798
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial Base Editing: Recent Advances towards Therapeutic Opportunities

Abstract: Mitochondria are critical organelles that form networks within our cells, generate energy dynamically, contribute to diverse cell and organ function, and produce a variety of critical signaling molecules, such as cortisol. This intracellular microbiome can differ between cells, tissues, and organs. Mitochondria can change with disease, age, and in response to the environment. Single nucleotide variants in the circular genomes of human mitochondrial DNA are associated with many different life-threatening diseas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 15 publications
(5 citation statements)
references
References 100 publications
0
5
0
Order By: Relevance
“…Nevertheless, the result here suggests the mitochondrial version of humanin must be important because its peptide sequence has been conserved throughout vertebrate evolution. The nuclear versions might also be important, and they warrant further study, such as using CRISPR techniques to alter or knock out the numts, and methods of introducing base changes into mitochondrial genes are on the horizon 21 .…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, the result here suggests the mitochondrial version of humanin must be important because its peptide sequence has been conserved throughout vertebrate evolution. The nuclear versions might also be important, and they warrant further study, such as using CRISPR techniques to alter or knock out the numts, and methods of introducing base changes into mitochondrial genes are on the horizon 21 .…”
Section: Discussionmentioning
confidence: 99%
“…The second approach does not try to decrease the heteroplasmy level but simply to correct the mutated base [66]. This concept has been recently described by Kar et al [67].…”
Section: Discussionmentioning
confidence: 99%
“…The current mtDNA editing tools, such as restriction endonucleases, zinc finger nucleases (mitoZFNs), transcription activator-like effector nucleases (mitoTALENs) and mito-Tev-TALE, have many drawbacks to efficiently eliminate mutant mtDNA, thereby preventing their use in clinical setting [ 91 ]. Novel promising molecular tools, such as the protein-based editor Double-stranded DNA deaminase (DddA) [ 92 ] and mitochondrial-targeted meganucleases (mitoARCUS) [ 93 ] are being developed [ 94 ]. Thus, the technology of editing mtDNA is still years behind with lots of different types of hurdles to overcome before transitioning to clinical therapy.…”
Section: Challenges In Clinical Testing For Primary Mitochondrial Dis...mentioning
confidence: 99%